Etavopivat
Showing 1 - 4 of 4
Sickle Cell Disease Trial in Atlanta (Etavopivat)
Not yet recruiting
- Sickle Cell Disease
- Etavopivat
-
Atlanta, GeorgiaEmory University Children's Healthcare of Atlanta
Feb 10, 2023
Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)
Recruiting
- Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
- Etavopivat
-
Ocala, Florida
- +3 more
Jan 30, 2023
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022